Translation Research Funding

In 2007, CDC’s Office of Public Health Genomics announced a new funding opportunity for those interested in genomic translation research. The funding opportunity announcement (FOA), entitled “Genomic Applications in Practice and Prevention: Translation Research,” offered award amounts from $200,000 to $350,000.

This FOA sought applications to conduct research that would accelerate the translation of genomics into public health practice, in such areas as cancer, diabetes, educational and community-based programs, heart disease, stroke, and mental health. Such research will advance knowledge about the validity, utility, utilization, and population health impact of genomic and family health history applications for improving health and preventing disease.

Focusing on filling the gaps within current translation research, including those identified through systematic review processes, this FOA will build upon current evidence-based guidelines to integrate genomics into clinical and public health practice.

Read more information on OPHG-funded genomics translation research programs.

Translation Program Funding

In 2008, CDC’s Office of Public Health Genomics announced a new funding opportunity called Genomics Applications in Practice and Prevention (GAPP): Translation Programs in Education, Surveillance, and Policy. Award amounts ranged from $150,000 to $300,000.

This funding supports programs involving health education, surveillance, and policy interventions related to genomic applications, such as genetic tests and family health history, targeted to large, well-defined populations or clinical practice settings in the United States. The goal of these funded programs is to move genomics applications along the translation research continuum phases T2 through T4 (i.e., from development of evidence-based guidelines to outcomes research) in a manner that maximizes health benefits and minimizes harm to individuals and populations.

Such programs are needed to support the development of guidelines and policies for the appropriate use of genomic applications in clinical and public health practice, to increase understanding among health professionals and consumers of potential harms and benefits of these applications, and to conduct ongoing surveillance to assess the degree to which these applications are being used and to assess outcomes in individuals and populations.

Read more information on OPHG-funded genomics translation programs.

For a list of current CDC FOAs, please visit:

Page last reviewed: November 18, 2010 (archived document)